Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Interaction Study of Rezdiffra With Pioglitazone
NCT04671056Phase 1Completed
- Sponsor
- Madrigal Pharmaceuticals
- Start
- Nov 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of resmetirom in Nonalcoholic steatohepatitis (NASH), sponsored by Madrigal Pharmaceuticals. Primary endpoint: Area Under the Curve at 17 days. Started Nov 2018; status: completed.
02
Drugs
resmetirom
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04671056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04671056.